Please login to the form below

Not currently logged in
Email:
Password:

Bayer picks up PMEA award for multi-channel engagement

Close-run category sees its iMCM Lighthouse Project triumph

Bayer

Bayer’s iMCM Lighthouse Project was awarded the Excellence in Engagement through Multiple Channels at last week’s 2017 PMEA Awards in London.

The work, delivered with support from digital agency Oi, provided a novel approach to restoring growth to Bayer’s established testosterone market leader Nebido.

It did this by helping UK healthcare professionals identify and treat patients with hypogonadism, a condition that is under-diagnosed and under-treated by clinicians.

The campaign was built upon the core foundation of a traditional educational programme, in the form of ‘Restore the Man’ clinical seminars, with an integrated multichannel strategy wrapped around it.

An intelligent matrix of content that evolved customer conversations across channels was provided and Nebido returned to growth in 2016, with sales up by 9%.

The PMEA judges said: “Bayer’s project is an excellent demonstration of an omni-channel campaign. They had clear audience segmentation with a wide range of content and channels. It is a very worthwhile project, with a journey that works end-to-end.”

The Engagement through Multiple Channels also saw two high commendations: Skin-telligence by Cetraben with support from Pegasus and the Growth Hormone eHealth Programme by Merck KGaA with support from W2O Group.

Run by PMLiVE’s publisher the PMGroup, PMEA exists to reward responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

The programme has been specifically designed to recognise and commend excellence, best practice and innovation in local, European and international markets.

* See all the results from PMEA 2017

* View the PMEA 2017 photo gallery

Article by
Dominic Tyer

21st November 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics